2,3-dihydrobenzo[b]thiophene derivatives as hypoxia inducible factor-2(alpha) inhibitors
US-12171741-B2 · Dec 24, 2024 · US
US9537102B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9537102-B2 |
| Application number | US-201313910246-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 5, 2013 |
| Priority date | Jun 5, 2012 |
| Publication date | Jan 3, 2017 |
| Grant date | Jan 3, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A low-molecular-weight fused polycyclic heteroaromatic compound may have a compact planar structure in which seven or more rings are fused together, and thereby exhibits high charge mobility, and furthermore, enables the use of a deposition process or a room-temperature solution process when applied to devices, therefore realizing improved processibility. An organic thin film and electronic device may include the fused polycyclic heteroaromatic compound.
Opening claim text (preview).
What is claimed is: 1. A fused polycyclic heteroaromatic compound comprising a structural unit represented by the following Chemical Formula 1: wherein, in the above Chemical Formula 1, Ar is one of a substituted or unsubstituted benzene, a substituted or unsubstituted naphthalene, and a substituted or unsubstituted anthracene, each of X 1 to X 4 are independently one of O, S, Se, Te, N—R a , and CR b , wherein each of R a and R b are independently one of hydrogen, a substituted or unsubstituted linear or branched C 1 to C 30 alkyl group, a substituted or unsubstituted C 7 to C 30 arylalkyl group, a substituted or unsubstituted C 6 to C 30 aryl group, a substituted or unsubstituted C 1 to C 30 alkoxy group, —OR 11 , wherein R 11 is a substituted or unsubstituted C 6 to C 30 aryl group, a substituted or unsubstituted C 4 to C 30 cycloalkyl group, —OR 12 , wherein R 12 is a substituted or unsubstituted C 4 to C 30 cycloalkyl group, a substituted or unsubstituted C 2 to C 30 heteroaryl group, —C(═O)R 13 , wherein R 13 is a substituted or unsubstituted C 1 to C 30 alkyl group, —S(═O) 2 R 14 , wherein R 14 is a substituted or unsubstituted C 1 to C 30 alkyl group, and —NHC(═O)OR 15 , wherein R 15 is a substituted or unsubstituted C 1 to C 30 alkyl group, at least one of X 1 and X 2 is selected from O, S, Se, and Te, at least one of X 3 and X 4 is selected from O, S, Se, and Te, each of X 5 and X 6 are independently one of O, S, Se, Te, and CR b R c wherein each of R b to R c are independently one of hydrogen, a substituted or unsubstituted linear or branched C 1 to C 30 alkyl group, a substituted or unsubstituted C 7 to C 30 arylalkyl group, a substituted or unsubstituted C 6 to C 30 aryl group, a substituted or unsubstituted C 1 to C 30 alkoxy group, —OR 11 , wherein R 11 is a substituted or unsubstituted C 6 to C 30 aryl group, a substituted or unsubstituted C 4 to C 30 cycloalkyl group, —OR 12 , wherein R 12 is a substituted or unsubstituted C 4 to C 30 cycloalkyl group, a substituted or unsubstituted C 2 to C 30 heteroaryl group, —C(═O)R 13 , wherein R 13 is a substituted or unsubstituted C 1 to C 30 alkyl group, —S(═O) 2 R 14 , wherein R 14 is a substituted or unsubstituted C 1 to C 30 alkyl group, and —NHC(═O)OR 15 , wherein R 15 is a substituted or unsubstituted C 1 to C 30 alkyl group, and each of R 1 to R 6 are independently one of hydrogen, —F, —Cl, —Br, —I, a substituted or unsubstituted linear or branched C 1 to C 30 alkyl group, a substituted or unsubstituted linear or branched C 2 to C 30 alkenyl group, a substituted or unsubstituted linear or branched C 2 to C 30 alkynyl group, a substituted or unsubstituted C 7 to C 30 arylalkyl group, a substituted or unsubstituted C 2 to C 30 heteroarylalkyl group, a substituted or unsubstituted C 2 to C 30 alkylheteroaryl group, a substituted or unsubstituted C 5 to C 30 cycloalkyl group, a substituted or unsubstituted C 2 to C 30 heterocycloalkyl group, a substituted or unsubstituted C 6 to C 30 aryl group, and a substituted or unsubstituted C 2 to C 30 heteroaryl group. 2. The fused polycyclic heteroaromatic compound of claim 1 , wherein the fused polycyclic heteroaromatic compound is represented by the following Chemical Formula 1A: wherein, in the above Chemical Formula 1A, each of X 1 to X 4 are independently one of O, S, Se, Te, N—R a , and CR b , wherein each of R a and R b are independently one of hydrogen, a substituted or unsubstituted linear or branched C 1 to C 30 alkyl group, a substituted or unsubstituted C 7 to C 30 arylalkyl group, a substituted or unsubstituted C 6 to C 30 aryl group, a substituted or unsubstituted C 1 to C 30 alkoxy group, —OR 11 , wherein R 11 is a substituted or unsubstituted C 6 to C 30 aryl group), a substituted or unsubstituted C 4 to C 30 cycloalkyl group, —OR 12 , wherein R 12 is a substituted or unsubstituted C 4 to C 30 cycloalkyl group, a substituted or unsubstituted C 2 to C 30 heteroaryl group, —C(═O)R 13 , wherein R 13 is a substituted or unsubstituted C 1 to C 30 alkyl group, —S(═O) 2 R 14 , wherein R 14 is a substituted or unsubstituted C 1 to C 30 alkyl group, and —NHC(═O)OR 15 , wherein R 15 is a substituted or unsubstituted C 1 to C 30 alkyl group, at least one of X 1 and X 2 is selected from O, S, Se, and Te, at least one of X 3 and X 4 is selected from O, S, Se, and Te, each of X 5 and X 6 are independently one of O, S, Se, Te, and CR b R c wherein each of R b to R c are independently one of hydrogen, a substituted or unsubstituted linear or branched C 1 to C 30 alkyl group, a substituted or unsubstituted C 7 to C 30 arylalkyl group, a substituted or unsubstituted C 6 to C 30 aryl group, a substituted or unsubstituted C 1 to C 30 alkoxy group, —OR 11 , wherein R 11 is a substituted or unsubstituted C 6 to C 30 aryl group, a substituted or unsubstituted C 4 to C 30 cycloalkyl group, —OR 12 , wherein R 12 is a substituted or unsubstituted C 4 to C 30 cycloalkyl group, a substituted or unsubstituted C 2 to C 30 heteroaryl group, —C(═O)R 13 , wherein R 13 is a substituted or unsubstituted C 1 to C 30 alkyl group, —S(═O) 2 R 14 , wherein R 14 is a substituted or unsubstituted C 1 to C 30 alkyl group, and —NHC(═O)OR 15 , wherein R 15 is a substituted or unsubstituted C 1 to C 30 alkyl group, each of R 1 to R 6 are independently one of hydrogen, —F, —Cl, —Br, —I, a substituted or unsubstituted linear or branched C 1 to C 30 alkyl group, a substituted or unsubstituted linear or branched C 2 to C 30 alkenyl group, a substituted or unsubstituted linear or branched C 2 to C 30 alkynyl group, a substituted or unsubstituted C 7 to C 30 arylalkyl group, a substituted or unsubstituted C 2 to C 30 heteroarylalkyl group, a substituted or unsubstituted C 2 to C 30 alkylheteroaryl group, a substituted or unsubstituted C 5 to C 30 cycloalkyl group, a substituted or unsubstituted C 2 to C 30 heterocycloalkyl group, a substituted or unsubstituted C 6 to C 30 aryl group, and a substituted or unsubstituted C 2 to C 30 heteroaryl group, R 100 is hydrogen, —F, —Cl, —Br, —I, a substituted or unsubstituted linear or branched C 1 to C 30 alkyl group, a substituted or unsubstituted linear or branched C 2 to C 30 alkenyl group, a substituted or unsubstituted linear or branched C 2 to C 30 alkynyl group, a substituted or unsubstituted C 7 to C 30 arylalkyl group, a substituted or unsubstituted C 2 to C 30 heteroarylalkyl group, a substituted or unsubstituted C 2 to C 30 alkylheteroaryl group, a substituted or unsubstituted C 5 to C 30 cycloalkyl group, a substituted or unsubstituted C 2 to C 30 heterocycloalkyl group, a substituted or unsubstituted C 6 to C 30 aryl group, or a substituted or unsubstituted C 2 to C 30 heteroaryl group, and x is an integer of 1 or 2. 3. The fused polycyclic heteroaromatic compound of claim 2 , wherein, in Chemical Formula 1A, each of R 1 to R 6 are independently one of a substituted or unsubstituted linear or branched C 1 to C 30 alkyl group, a substituted or unsubstituted linear or branched C 2 to C 30 alkenyl group, a substituted or unsubstituted linear or branched C 2 to C 30 alkynyl group, a substituted or unsubstituted C 7 to C 30 arylalkyl group, a substituted or unsubstituted C 2 to C 30 heteroarylalkyl group, a substituted or unsubstituted C 2 to C 30 alkylheteroaryl group, a substituted or unsubstituted C 5 to C 30 cycloa
Organic PV cells · CPC title
Ortho-condensed systems · CPC title
Electricity · mapped topic
Electricity · mapped topic
Electricity · mapped topic
Related publications grouped by family.
Answers are generated from the same data shown on this page.